IL143994A0 - Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells - Google Patents

Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Info

Publication number
IL143994A0
IL143994A0 IL14399499A IL14399499A IL143994A0 IL 143994 A0 IL143994 A0 IL 143994A0 IL 14399499 A IL14399499 A IL 14399499A IL 14399499 A IL14399499 A IL 14399499A IL 143994 A0 IL143994 A0 IL 143994A0
Authority
IL
Israel
Prior art keywords
growth hormone
human growth
stem cells
hematopoietic stem
pluripotent hematopoietic
Prior art date
Application number
IL14399499A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL143994A0 publication Critical patent/IL143994A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/27Growth hormone [GH], i.e. somatotropin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL14399499A 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells IL143994A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98124834A EP1016413A1 (en) 1998-12-30 1998-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
PCT/EP1999/010470 WO2000040260A1 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Publications (1)

Publication Number Publication Date
IL143994A0 true IL143994A0 (en) 2002-04-21

Family

ID=8233268

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14399499A IL143994A0 (en) 1998-12-30 1999-12-30 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells
IL143994A IL143994A (en) 1998-12-30 2001-06-26 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL143994A IL143994A (en) 1998-12-30 2001-06-26 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells

Country Status (15)

Country Link
US (1) US20060029581A1 (es)
EP (3) EP1016413A1 (es)
JP (1) JP4808316B2 (es)
AT (1) ATE342064T1 (es)
AU (2) AU772222B2 (es)
BR (1) BR9916726A (es)
CA (1) CA2354194A1 (es)
CY (1) CY1107603T1 (es)
DE (1) DE69933581T2 (es)
DK (1) DK1140149T3 (es)
ES (1) ES2275359T3 (es)
IL (2) IL143994A0 (es)
PT (1) PT1140149E (es)
SI (1) SI1140149T1 (es)
WO (1) WO2000040260A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2330193T3 (es) * 2000-06-07 2009-12-07 Merck Serono Sa Hormona de crecimiento humano para estimular la movilizacion de celulas madre hematopoyeticas pluripotentes.
AU8617301A (en) 2000-08-01 2002-02-13 Yissum Res Dev Co Directed differentiation of embryonic cells
MXPA04000982A (es) 2001-07-31 2004-04-20 Anormed Inc Metodos para movilizar celulas progenitoras/madre.
CA2540529C (en) 2003-10-03 2012-03-13 Vib Vzw Means and methods for the recruitment and identification of stem cells
JP2005289837A (ja) * 2004-03-31 2005-10-20 Juntendo 骨髄細胞誘導剤の製造方法及び製造装置
US7816320B2 (en) * 2004-12-22 2010-10-19 Ambrx, Inc. Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35
NZ600363A (en) * 2009-12-21 2014-07-25 Ambrx Inc Modified porcine somatotropin polypeptides and their uses

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5649904A (en) * 1988-10-07 1997-07-22 Sandoz Ltd. Method of treating cancer with a fully myeloablative regimen of chemotherapy, radiation or both
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
EP0563485A1 (en) * 1992-03-30 1993-10-06 Schering-Plough In vitro generation of human dendritic cells and uses thereof
WO1994028916A1 (en) * 1993-06-15 1994-12-22 British Biotech Pharmaceuticals Limited Release and mobilisation of haematopoietic cells
JPH07101877A (ja) * 1993-10-04 1995-04-18 Mitsui Toatsu Chem Inc 血小板減少症治療剤
DE69433967D1 (de) * 1993-10-06 2004-09-30 Univ Florida Stammzellen-proliferations-faktor
JPH0892001A (ja) * 1994-09-26 1996-04-09 Asahi Medical Co Ltd 細胞集団の保存方法
WO1997003684A1 (en) * 1995-07-21 1997-02-06 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Method of decreasing radiation or radio-mimetic chemotherapy for hematopoietic pluripotent cell engraftment
JP2000503542A (ja) * 1996-01-16 2000-03-28 デピュイ オーソピーディック,インコーポレイテッド 造血及び非造血組織からの前駆細胞の分離及び in vivo 骨及び軟骨再生におけるそれらの使用
JP4042925B2 (ja) * 1996-11-20 2008-02-06 シスメックス株式会社 幼若白血球の分類計数法
JPH10295369A (ja) * 1997-02-26 1998-11-10 Japan Tobacco Inc 造血幹細胞の製造方法
SE9804064D0 (sv) * 1998-11-25 1998-11-25 A & Science Invest Ab Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
EP1016414B1 (en) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Human growth hormone to stimulate hematopoiesis and immune reconstitution after hematopoietic stem cell transplantation in humans
ES2330193T3 (es) * 2000-06-07 2009-12-07 Merck Serono Sa Hormona de crecimiento humano para estimular la movilizacion de celulas madre hematopoyeticas pluripotentes.
US7220407B2 (en) * 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction

Also Published As

Publication number Publication date
JP4808316B2 (ja) 2011-11-02
CY1107603T1 (el) 2013-03-13
ES2275359T3 (es) 2007-06-01
AU2103900A (en) 2000-07-24
AU772222B2 (en) 2004-04-22
SI1140149T1 (sl) 2007-02-28
WO2000040260A1 (en) 2000-07-13
JP2002534393A (ja) 2002-10-15
ATE342064T1 (de) 2006-11-15
EP1140149B1 (en) 2006-10-11
CA2354194A1 (en) 2000-07-13
BR9916726A (pt) 2001-09-11
PT1140149E (pt) 2007-01-31
DE69933581T2 (de) 2007-06-21
US20060029581A1 (en) 2006-02-09
EP1140149A1 (en) 2001-10-10
AU2004203355B2 (en) 2007-05-17
DE69933581D1 (de) 2006-11-23
AU2004203355A1 (en) 2004-08-19
IL143994A (en) 2009-06-15
DK1140149T3 (da) 2007-02-19
EP1016413A1 (en) 2000-07-05
EP1779865A1 (en) 2007-05-02

Similar Documents

Publication Publication Date Title
IL147990A0 (en) Multipotent adult stem cells and methods for isolation
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
WO2001021766A8 (en) Methods and devices for obtaining non-hematopoietic lineage cells from hematopoietic progenitor cells
AU4094099A (en) Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells
WO2003004605A3 (en) Mesenchymal cells and osteoblasts from human embryonic stem cell
AU2003209259A8 (en) Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
AU2003285172A8 (en) Human embryonic stem cell cultures, and compositions and methods for growing same
WO2003104443A3 (de) Mesenchymale stammzellen des haarfollikels und deren verwendung
IL159580A0 (en) Cells of the cardiomyocyte lineage produced from human pluripotent stem cells
SG147437A1 (en) Crystalline form of gamma-aminobutyric acid analog
WO2003018751A3 (en) Apparatus and method for electroporation of biological samples
AU7328601A (en) Skin care compositions containing silicone elastomers
WO2003027247A3 (en) Modulation of stem cells using zinc finger proteins
ATE444078T1 (de) Menschliches wachstumshormon zur stimulierung der mobilisierung pluripotenter hämapoietischer stammzellen
CY1107603T1 (el) Χρηση της ανθρωπινης ορμονης αναπτυξης για την αυξηση του αριθμου των κυκλοφορουντων κυτταρων cd34+, με στοχο την ανασυνθεση των αιματοποιητικων και ανοσοποιητικων συστηματων ακολουθωντας μυελοβλαστικες ή αντιβλαστικες θepαπειες, μεσω μεταμοσχευσης, επαναμεταγγισης ή εμφυτευσης
GB9925964D0 (en) Hair transplantation
HK1048498A1 (zh) 自然殺傷細胞的增殖方法
WO2000066731A3 (en) Recombinant laminin 5
HUP0102293A2 (hu) Interleukin-6 termelődését serkentő vegyületet tartalmazó kozmetikai kompozíció
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2003062197A3 (en) Nek2 inhibitors
WO2003011313A8 (en) Osteogenic growth oligopeptides as stimulants of hematopoiesis
ZA200401134B (en) Growth of human mesenchymal stem cells (hMSC) using umbilical cord blood serum and the method for the preparation thereof.
UA36385A (uk) Спосіб лікування генералізованого пародонтиту
UA30970A (uk) Спосіб лікування пульпіту